Suloctidil

CHEMBL404849 Phase 4 Zugelassen Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

337.6 g/mol

LogP

5.8

Phase

4

Suloctidil is a vasoactive compound with calcium channel blocking and anti-platelet aggregation properties, used historically in some countries for the treatment of peripheral and cerebral vascular insufficiency and claudication. It reduces vascular smooth muscle tone and inhibits platelet function, improving blood flow in atherosclerotic vessels. It has been withdrawn from many markets due to hepatotoxicity concerns.

Molekularmasse

337,6000 g/mol

LogP

5,80

TPSA

57,60 Å²

Lipinski-Regel der Fünf

Bestanden

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure

Embed this structure

SMILES

CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1

InChI

InChI=1S/C20H35NOS/c1-5-6-7-8-9-10-15-21-17(4)20(22)18-11-13-19(14-12-18)23-16(2)3/h11-14,16-17,20-22H,5-10,15H2,1-4H3

Molecular Formula

C20H35NOS

HBD / HBA

2 / 3

Rotierbare Bindungen

12

Schwere Atome

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

Suloctidil is a vasoactive compound with calcium channel blocking and anti-platelet aggregation properties, used historically in some countries for the treatment of peripheral and cerebral vascular insufficiency and claudication. It reduces vascular smooth muscle tone and inhibits platelet function, improving blood flow in atherosclerotic vessels. It has been withdrawn from many markets due to hepatotoxicity concerns.

Yes, Suloctidil is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL404849. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 6604413. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Suloctidil auf PillFYI

Struktur

Schnelldaten

Formel: C20H35NOS

Externe Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.